The International Parkinson and Movement Disorders Society (MDS) is a global professional society dedicated to the study and treatment of movement disorders, including Progressive Supranuclear Palsy (PSP), Parkinson's disease, Huntington's disease, and other neurodegenerative conditions affecting movement.
| Attribute | Details |
|---|---|
| Organization Name | International Parkinson and Movement Disorders Society |
| Abbreviation | MDS |
| Founded | 1990 (as Movement Disorders Society) |
| Headquarters | Milwaukee, Wisconsin, USA |
| Focus | Movement disorders research and clinical care |
| Members | 10,000+ neurologists, researchers, healthcare professionals worldwide |
| Official Journal | Movement Disorders |
| Official Journal: Clinical Practice | Movement Disorders Clinical Practice |
MDS aims to:
The MDS Annual International Congress is the premier gathering for movement disorders specialists worldwide:
The society supports clinical and research fellowships:
MDS publishes evidence-based guidelines including:
MDS has dedicated groups for:
MDS is the primary professional organization for PSP researchers and clinicians:
| Contribution | Description |
|---|---|
| Research Collaboration | International PSP genetics and biomarker studies |
| Clinical Guidelines | MDS criteria for PSP diagnosis and staging |
| Education | Annual congress sessions dedicated to PSP |
| Advocacy | Support for PSP research funding initiatives |
MDS is governed by:
MDS Consensus Criteria (2017): Established revised diagnostic criteria for PSP, improving diagnostic sensitivity 1
MDS-UPDRS: Developed the Unified Parkinson's Disease Rating Scale, now the gold standard for PD clinical trials
International PSP Genetics Consortium: Supported large-scale genetic studies identifying PSP risk genes
TauRx Trials: Published pivotal papers on tau-targeting therapeutics in Movement Disorders journal